Reach Us +44-1647-403003
Primary Intramedullary Melanocytoma: A Case Report | OMICS International | Abstract
ISSN: 2165-7920

Journal of Clinical Case Reports
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Primary Intramedullary Melanocytoma: A Case Report

Gokmen Kahilogullari*
Ankara Universitesi Ibni Sina Hastanesi Norosirurji ABD Sihhiye/ANKARA, Turkey
Corresponding Author : Gokmen Kahilogullari
Ankara Universitesi Ibni Sina Hastanesi
Norosirurji ABD Sihhiye/ANKARA, Turkey
E-mail: [email protected]
Received March 13, 2012; Accepted April 06, 2012; Published April 18, 2012
Citation: Kahilogullari G (2012) Primary Intramedullary Melanocytoma: A Case Report. J Clinic Case Reports 2:123. doi:10.4172/2165-7920.1000123
Copyright: © 2012 Kahilogullari G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


We report herein a case of primary intramedullary melanocytoma in a 28-year-old female. She presented with a 3-year history of back pain with paresthesia and dysesthesia of the right lower extremity. Magnetic resonance imaging showed an intramedullary mass located at the T11-12 level. The tumor was removed totally. The histopathological diagnosis was melanocytoma. Intramedullary melanocytomas are rare lesions, and this is only the 20th case described in the literature. Though known as benign tumors, local recurrence and the aggressive behavior of melanocytomas must be kept in mind, even following total resection.


Recommended Conferences

14th Global Pharmacovigilance And Clinical Trials Summit

Sydney, Australia

38th International Conference on Dental & Oral Care

Yokohama, Japan

World Conference on Clinical and Medical Case Reports

Perth, Australia
Share This Page